Consuming marijuana via inhalation was effective in providing migraine relief, according to a study published online by the National Library of Medicine.
For this randomized, double-blind, placebo-controlled, crossover trial, researchers at the University of California examined 92 patients with persistent migraines. Patients treated up to four separate migraine attacks, “one each with vaporized 1) 6% tetrahydrocannabinol (THC-dominant); 2) 11% cannabidiol (CBD-dominant); 3) 6% THC+11% CBD; and 4) placebo cannabis flower in a randomized order.”
Researchers found that “Vaporized 6% THC+11% CBD cannabis flower was superior to placebo for pain relief, pain freedom, and MBS [most bothersome symptom] freedom at 2 hours as well as 24-hour sustained pain freedom and sustained MBS freedom and 48-hour sustained MBS freedom.”
Continue reading